Lata Jayaraman

Company: Frontier Medicines

Job title: Head Senior VP, Oncology & Inflammation Research

Seminars:

Increasing the Scope of Covalent Drugs to Transcription Factors & Hard to Drug Proteins with Strategic Target Selection 8:30 am

Defining what makes a good target considering half life, non-covalent secondary interactions and ligandability Utilising modelling and ML to define pockets and calculate pocket size, solvent accessible surface area and PKa Strategies to reach previously undruggable targets with covalent modalitiesRead more

day: Day One